Skip to content

Immulite Rubella Quantitative IgG, Catalog # LKRBQ1 (100 Tests), LKRBQ5 (500 Tests)

by Diagnostic Products Corp.

510(k) K982078

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK982078 Date11 Dec 1998ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LFX
Device Class
Class II
Regulation
21 CFR Part 866.3510
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Immulite Rubella Quantitative IgG is an enzyme-linked immunoabsorbent assay (ELISA) designed for the quantitative measurement of IgG antibodies to rubella virus in human serum. It functions as a solid-phase chemiluminescent immunoassay, providing objective detection of rubella immunity. This device aids in assessing immune status, particularly for women of childbearing age, to determine susceptibility to rubella infection. The assay is intended for in vitro diagnostic use on the Immulite Automated Analyzer.

This assay is supplied as a single-use reagent kit for laboratory use, requiring no additional sterilization. It is classified under product code LFX and falls under FDA 510(k) clearance (K982078) as a Class II device under special controls for microbiology applications. The kits (LKRBQ1 for 100 tests, LKRBQ5 for 500 tests) are intended for use in clinical microbiology settings. Storage and handling must comply with standard in vitro diagnostic device protocols.

Other devices from Diagnostic Products Corp.

See all devices from Diagnostic Products Corp. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Immulite Rubella Quantitative IgG kit used for?

    This kit uses a solid-phase chemiluminescent immunoassay to measure IgG antibodies against the rubella virus in human serum. It helps determine whether a patient has immunity to rubella, particularly important for women of childbearing age to assess susceptibility to infection during pregnancy. The results provide objective data to guide clinical decisions about vaccination or infection risk.

  • How is the Immulite Rubella IgG kit supplied, and is it single-use?

    The kit is supplied as a single-use reagent kit, available in two configurations: LKRBQ1 for 100 tests and LKRBQ5 for 500 tests. Since it is designed for in vitro diagnostic use on the Immulite Automated Analyzer, each kit is intended for one-time use per its labeled capacity. No additional sterilization is required, as the kit is pre-packaged for laboratory use.

  • What storage and handling requirements apply to the Immulite Rubella IgG kit?

    The kit must be stored and handled according to standard protocols for in vitro diagnostic devices. While specific storage conditions (e.g., temperature) are not detailed here, it is critical to follow the manufacturer’s instructions included with the kit to maintain reagent integrity. Improper storage could compromise assay accuracy, so adherence to recommended guidelines is essential for reliable results.

  • Are there different sizes or models available for the Immulite Rubella IgG kit?

    Yes, the kit is available in two distinct sizes: LKRBQ1 for 100 tests and LKRBQ5 for 500 tests. The choice between models depends on laboratory volume and testing needs. Both versions are compatible with the Immulite Automated Analyzer and share the same assay methodology, ensuring consistency across different kit sizes.

  • What regulatory pathway does the Immulite Rubella IgG kit follow?

    The kit is classified as a Class II medical device under FDA 510(k) clearance (K982078) and falls under product code LFX for microbiology applications. It was determined to be substantially equivalent to a predicate device through a traditional review process by the FDA’s Microbiology (MI) Advisory Committee. This classification reflects its use in clinical microbiology settings for diagnostic purposes.